Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell cycle checkpoint protein RAD1 is a core subunit of the heterotrimeric 9-1-1 clamp complex, which is essential for DNA damage checkpoint activation and DNA repair. Upon sensing DNA damage or replication stress, the 9-1-1 complex (comprising RAD9, RAD1, and HUS1) is loaded onto chromatin by the RAD17 complex, acting as a surveillance platform that recruits and stimulates various DNA repair enzymes. RAD1 plays a regulatory and structural role within the 9-1-1 complex, enabling interactions with DNA polymerases, endonucleases, ligases, and glycosylases involved in multiple DNA repair pathways. Through these functions, RAD1 is critical for maintaining genome stability, preventing cell cycle progression when DNA is damaged, and facilitating accurate DNA repair, particularly during DNA replication and meiosis[1][2][3][4]. Loss or dysfunction of RAD1 can lead to defective DNA damage responses, genomic instability, and is implicated in cancer predisposition syndromes.
No direct pharmacological mechanism; the target is not currently drugged, but inhibition or modulation would theoretically affect DNA damage response and repair
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell cycle checkpoint protein RAD1 (RAD1).